tag safe-medication-practices 
Rethinking Clinical Trials
JANUARY 31, 2024
DIHI approaches this work through four pillars of innovation: implementation and health delivery science, health technology innovation, leadership and workforce development, and best practices development and dissemination. The next phase of work is building out a practice network in building AI capabilities.
Rethinking Clinical Trials
FEBRUARY 28, 2024
But there are concerns to developing DCTs including lack of standardization and validation, regulatory and ethical uncertainties, engagement vs. coercion, data security and privacy issues, technological literacy and access, resistance to change and adoption, and lack of “safe” sharing. from 2021 to 2026. I think we must.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 15, 2020
“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. As part of this, a number of big pharma companies are also racing to develop a safe and effective vaccine for the coronavirus.
XTalks
AUGUST 23, 2021
The first two principles are the need for data validity and for a study’s purpose to be to change clinical practice — two important tenants of all biomedical research. While this design has the same benefit of the previous to inform clinical practice, it will be both time-consuming and expensive.
XTalks
JANUARY 19, 2024
Briner, known as the father of radiopharmacy, having paved the way for its practice, the use of radiopharmaceuticals in medicine continues to grow and evolve. Omer Nawaz, PhD, Molecular Imaging Director of an emerging biotech, and Michael Lamba, PhD, DABR, Academic Medical Physicist, explored recent breakthroughs in radiotherapy.
Expert insights. Personalized for you.
161 
Let's personalize your content